TrialClinics (Sao Paulo, Brazil)2014

Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.

Marcelo E Ochiai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.